Clinical trial
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or…
NCT00356603 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00356603 |
|---|---|
| Title | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan |
| Official title | Imigran STATdose - Japan Clinical Experience Study for Self-injection |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Disorders |
| Intervention type | Drug |
| Interventions | Sumatriptan Succinate |
| Enrollment | 75 |
| Start date | Jun 20, 2006 |
| Primary completion | Aug 7, 2006 |
| Completion | Aug 7, 2006 |
| First posted | Jul 26, 2006 |
| Last update posted | Sep 4, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: